|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$23.86 |
$24.14 |
$23.62 |
$23.76 |
1.80M | 04/19/2024 |
$23.65 |
$23.87 |
$23.48 |
$23.85 |
2.41M | 04/22/2024 |
$24.08 |
$24.19 |
$23.76 |
$24.07 |
1.71M | 04/23/2024 |
$24.09 |
$24.63 |
$24.06 |
$24.26 |
1.25M | 04/24/2024 |
$24.26 |
$24.81 |
$24.16 |
$24.65 |
1.74M |
|
Alkermes is a biopharmaceutical company. Co. has a portfolio of commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of product candidates in development for neurological disorders and cancer. Co.'s proprietary products include: ARISTADA, which is an extended-release intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO, which utilizes Co.'s proprietary LinkeRx and NanoCrystal technologies; and LYBALVI, which is an oral atypical antipsychotic drug approved in the U.S. for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder. | |
|
Alkermes (ALKS) has the following price history information. Looking back at ALKS historical stock prices for the last five trading days, on April 18, 2024, ALKS opened at $23.86, traded as high as $24.14 and as low as $23.62, and closed at $23.76. Trading volume was a total of 1.80M shares. On April 19, 2024, ALKS opened at $23.65, traded as high as $23.87 and as low as $23.48, and closed at $23.85. Trading volume was a total of 2.41M shares. On April 22, 2024, ALKS opened at $24.08, traded as high as $24.19 and as low as $23.76, and closed at $24.07. Trading volume was a total of 1.71M shares. On April 23, 2024, ALKS opened at $24.09, traded as high as $24.63 and as low as $24.06, and closed at $24.26. Trading volume was a total of 1.25M shares. On April 24, 2024, ALKS opened at $24.26, traded as high as $24.81 and as low as $24.16, and closed at $24.65. Trading volume was a total of 1.74M shares.
ALKS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alkermes shares, starting with a $10,000 purchase of ALKS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$45.45 |
|
End price/share: |
$24.65 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-45.76% |
|
Average Annual Total Return: |
-5.94% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,421.54 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $23.76 | 04/19/2024 | $23.85 | 04/22/2024 | $24.07 | 04/23/2024 | $24.26 | 04/24/2024 | $24.65 |
|
|